Evaluating Ebola therapies--the case for RCTs
N Engl J Med
.
2014 Dec 18;371(25):2350-1.
doi: 10.1056/NEJMp1414145.
Epub 2014 Dec 3.
Authors
Edward Cox
1
,
Luciana Borio
,
Robert Temple
Affiliation
1
From the Center for Drug Evaluation and Research (E.C., R.T.) and the Office of the Commissioner (L.B.), Food and Drug Administration, Silver Spring, MD.
PMID:
25470568
DOI:
10.1056/NEJMp1414145
No abstract available
MeSH terms
Ebolavirus
Epidemics
Hemorrhagic Fever, Ebola / epidemiology
Hemorrhagic Fever, Ebola / mortality
Hemorrhagic Fever, Ebola / therapy*
Humans
Randomized Controlled Trials as Topic*